-
サマリー
あらすじ・解説
We see Cresset Drug Discovery's very own VP of Artificial Intelligence Mutlu Dogruel discuss all things AI, Drug Discovery and AGI.
Mutlu gives us a detailed overview of how AI is used in Drug Discovery, the dangers associated with this, mitigating them and how his team at Cresset are doing these very things.
Then, the topic of Artifificial General Intelligence (AGI) is covered, with some interesting thought experiments.
This podcast is powered by Strativ Group, talent solutions specialists in AI.
If you'd like to get involved in our Beyond the Model podcast series, reach out to our host Kieran at k.haynes@strativgroup.com.
Hosted on Acast. See acast.com/privacy for more information.